Lee Moffitt Cancer Center & Research Institute, recently completed a Phase I / II study conducted promising with the experimental drug Revlimid as an innovative way to help patients with myelodysplastic syndrome , a form of pre – leukemia. Given the same in the form of tablets, Revlimid blocked the growth of new blood vessels that supply tumors , and stimulates the immune system The study cancer cells. The study is reported in the Feb.10 issue of the New England Journal of Medicine.. Moffitt Doctor published Leukemia Drug Breakthrough Study in New England Journal of Medicinelist, head of the hematological malignancies program at the H.
Irwin Redlener, president of the Children’s Health Fund, said: It is not only the prioritization of the needs of children is doing the right thing, it is an essential part of emergency planning in general Failing to understand and react to. May undermine the needs of children in emergencies the entire response plan. . (more…)